Thalidomide is a notorious drug that caused horrific birth defects in the 1950s, though its damage in the U.S. was limited by Dr. Frances Oldham Kelsey and the FDA. Now, thalidomide has found a different use in the field of targeted protein degradation as part of a new class of therapeutics.
Continue Reading